Medtech Report

Medtech exits test a new future 

While VC dealmaking in the medtech sector dipped in Q2, activity is still on track to surpass last year and VC exits are on the rise, according to PitchBook’s latest Emerging Tech Research.  

Startups generated $3.3 billion across 206 deals, declines of 7.0% and 3.3%, respectively, from Q1. Notable fundraises in Q2 included molecular testing startup BillionToOne raising a $130 million Series D and focused ultrasound device-maker Insightec securing $150 million.  

PitchBook analyst Aaron DeGagne also highlights newly emerging opportunities for investors like startups in the sepsis testing and heart arrhythmia segments.